Short Interest in Vitrolife AB (publ) (OTCMKTS:VTRLY) Rises By 202.4%

Vitrolife AB (publ) (OTCMKTS:VTRLY) was the target of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 514 shares, a growth of 202.4% from the June 30th total of 170 shares. Based on an average daily trading volume, of 159 shares, the short-interest ratio is presently 3.2 days.

Vitrolife AB (publ) Stock Performance

VTRLY opened at $9.50 on Monday. Vitrolife AB has a one year low of $9.50 and a one year high of $18.55. The business’s 50 day moving average price is $10.51 and its 200 day moving average price is $11.36.

About Vitrolife AB (publ)

Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.

The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients.